Results 231 to 240 of about 6,023,930 (342)
Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts) [PDF]
Johanna C. Bendell +16 more
openalex +1 more source
Editorial: Cellular replacement therapy for diabetes. [PDF]
Sakata N, Yoshimatsu G, Kodama S.
europepmc +1 more source
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu +5 more
wiley +1 more source
Corneal macrophages and limbal stem cells: emerging roles in ocular surface regeneration. [PDF]
Mao Y +6 more
europepmc +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Prospective identification of tumorigenic prostate cancer stem cells.
A. Collins +4 more
semanticscholar +1 more source
Femoral stress distribution in fully hydroxyapatite-coated cementless versus polished cemented stems with identical geometry: a thermoelastic stress analysis. [PDF]
Watanabe R +5 more
europepmc +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Retracted: A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors
Stem Cells International
doaj +1 more source

